PRNewswire
IRVING, Texas
(NASDAQ-OTCBB:RBCL)
IRVING, Texas, June 16 /PRNewswire-FirstCall/ -- RBC Life Sciences:
(OTCBulletinBoard: RBCL) -- RBC Life Sciences, Inc., a provider of
proprietary nutritional supplements and wound care/pain management
products, announced today that all seven members of the board of
directors were re-elected during the company's 2009 shareholders
meeting.
RBC
Life Sciences CEO and President John W. Price opened the meeting
recapping the factors that led to the 13 percent growth in net sales
during 2008 and the company's prospects for continued growth throughout
2009. Despite the slow economy, an estimated 2,500 new independent
Associates have joined RBC Life Sciences during the last seven months
-- more than a 25 percent increase in the number of Associates the
company had when it launched efforts to build its North American sales
base in November 2008.
Re-elected
to the board of directors in the meeting were: Clinton H. Howard,
outside director and chairman of the board; Mr. Price; Steven E. Brown,
chief financial officer and vice president of finance; Kenneth L.
Sabot, senior vice president of operations; Paul Miller, president of
MPM Medical, Inc.; Joseph P. Phillip, independent director; and Robert
A. Kaiser, independent director.
About RBC Life SciencesRBC
Life Sciences develops, manufactures and markets high-quality
nutritional supplements and personal care products to a growing
population of consumers seeking wellness and a healthy lifestyle. Under
its MPM Medical
brand, RBC Life Sciences also develops and markets to health care
professionals in the United States proprietary prescription and
nonprescription products for advanced wound care and pain management.
All products are tested for quality assurance in-house, and by outside
independent laboratories, to comply with regulations in the U.S. and in
more than 30 countries in which the products are distributed. For more
information, visit the Company's Web site at www.rbclifesciences.com.
The
statements above, other than statements of historical fact, may be
forward-looking. Actual events will be dependent upon a number of
factors and risks including, but not limited to, changes in plans by
the Company's management, delays or problems in production, changes in
the regulatory process, changes in market trends, and a number of other
factors and risks described from time to time in the Company's filings
with the Securities and Exchange
SOURCE: RBC Life Sciences, Inc.
Web site: http://www.rbclifescience.com/